{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T23:21:48Z","timestamp":1771975308614,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijid.2020.10.065","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T22:37:21Z","timestamp":1603924641000},"page":"269-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0165-8934","authenticated-orcid":false,"given":"Tristan","family":"Delory","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabelle","family":"Goujon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Masson-Lecomte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Laurancon-Fretar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice","family":"Bercot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Mongiat-Artus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Lafaurie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"June (9)","key":"10.1016\/j.ijid.2020.10.065_bib0005","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/pros.22979","article-title":"Rapid increase in multidrug-resistant enteric bacilli blood stream infection after prostate biopsy-a 10-year population-based cohort study","volume":"75","author":"Aly","year":"2015","journal-title":"Prostate"},{"issue":"February (2)","key":"10.1016\/j.ijid.2020.10.065_bib0010","first-page":"181","article-title":"Hospital admissions after transrectal ultrasound-guided biopsy of the prostate in men diagnosed with prostate cancer: a database analysis in England","volume":"22","author":"Anastasiadis","year":"2015","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"key":"10.1016\/j.ijid.2020.10.065_bib0015","series-title":"Observatoire National de l\u2019Epid\u00e9miologie de la R\u00e9sistance Bact\u00e9rienne aux Antibiotiques (ONERBA): rapport d\u2019activit\u00e9 2017\/Annual Report 2017. [Internet]","author":"Anon","year":"2017"},{"issue":"June (6)","key":"10.1016\/j.ijid.2020.10.065_bib0020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.1464-410X.1996.01014.x","article-title":"Infection after transrectal core biopsies of the prostate\u2013risk factors and antibiotic prophylaxis","volume":"77","author":"Aus","year":"1996","journal-title":"Br J Urol"},{"issue":"February (2)","key":"10.1016\/j.ijid.2020.10.065_bib0025","first-page":"152","article-title":"Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study","volume":"21","author":"Campeggi","year":"2014","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"issue":"September (3)","key":"10.1016\/j.ijid.2020.10.065_bib0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","article-title":"Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?","volume":"62","author":"Carignan","year":"2012","journal-title":"Eur Urol"},{"issue":"May (5)","key":"10.1016\/j.ijid.2020.10.065_bib0035","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1128\/AAC.06122-11","article-title":"Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: MurA confers clinical resistance at low fitness cost","volume":"56","author":"Couce","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.ijid.2020.10.065_bib0040","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2217\/fmb.15.40","article-title":"Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance","volume":"10","author":"de Lastours","year":"2015","journal-title":"Future Microbiol"},{"issue":"September (3)","key":"10.1016\/j.ijid.2020.10.065_bib0045","first-page":"856","article-title":"Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study","volume":"166","author":"Djavan","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.ijid.2020.10.065_bib0050","series-title":"Surveillance of Antimicrobial Resistance in Europe 2018","author":"European Centre for Disease Prevention and Control","year":"2019"},{"issue":"September (3)","key":"10.1016\/j.ijid.2020.10.065_bib0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.aju.2016.05.003","article-title":"Fosfomycin antimicrobial prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a prospective randomised study","volume":"14","author":"Fahmy","year":"2016","journal-title":"Arab J Urol"},{"issue":"April (2)","key":"10.1016\/j.ijid.2020.10.065_bib0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/CMR.00068-15","article-title":"Fosfomycin","volume":"29","author":"Falagas","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2020.10.065_bib0065","series-title":"Complicated Urinary Tract Infections: Developing Drugs for Treatment Guidance for Industry [Internet]","author":"Food and Drug Administration","year":"2018"},{"issue":"February (4)","key":"10.1016\/j.ijid.2020.10.065_bib0070","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1093\/cid\/cit704","article-title":"Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?","volume":"58","author":"Gardiner","year":"2014","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"4","key":"10.1016\/j.ijid.2020.10.065_bib0075","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.juro.2016.11.081","article-title":"Indications, utilization and complications following prostate biopsy: New York State analysis","volume":"197","author":"Halpern","year":"2017","journal-title":"J Urol"},{"issue":"January (1)","key":"10.1016\/j.ijid.2020.10.065_bib0080","article-title":"Transrectal prostate biopsy-associated prophylaxis and infectious complications: report of a query to the emerging infections network of the infectious diseases society of America","volume":"2","author":"Johnson","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"November (12)","key":"10.1016\/j.ijid.2020.10.065_bib0085","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/cid\/ciz181","article-title":"Fosfomycin for injection (ZTI-01) versus Piperacillin-Tazobactam for the treatment of complicated urinary tract infection including acute pyelonephritis: ZEUS, a phase 2\/3 randomized trial","volume":"69","author":"Kaye","year":"2019","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"February (1)","key":"10.1016\/j.ijid.2020.10.065_bib0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF01643751","article-title":"Influence of fosfomycin on the intestinal and pharyngeal flora of man","volume":"19","author":"Knothe","year":"1991","journal-title":"Infection"},{"issue":"April (7)","key":"10.1016\/j.ijid.2020.10.065_bib0095","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/cid\/ciu1129","article-title":"Clinical and microbiological determinants of infection after transrectal prostate biopsy","volume":"60","author":"Liss","year":"2015","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"August","key":"10.1016\/j.ijid.2020.10.065_bib0100","article-title":"An update of the American urological association white paper on the prevention and treatment of the more common complications related to prostate biopsy","author":"Liss","year":"2017","journal-title":"J Urol [Internet]"},{"issue":"August (6)","key":"10.1016\/j.ijid.2020.10.065_bib0105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.acuro.2014.01.002","article-title":"Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin","volume":"38","author":"Lista","year":"2014","journal-title":"Actas Urol Esp"},{"issue":"November (5)","key":"10.1016\/j.ijid.2020.10.065_bib0110","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","article-title":"Complications after prostate biopsy: data from SEER-Medicare","volume":"186","author":"Loeb","year":"2011","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ijid.2020.10.065_bib0115","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"issue":"November (5)","key":"10.1016\/j.ijid.2020.10.065_bib0120","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1159\/000049840","article-title":"EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) working group of the health care office (HCO) of the European Association of Urology (EAU)","volume":"40","author":"Naber","year":"2001","journal-title":"Eur Urol"},{"issue":"January (1 Suppl)","key":"10.1016\/j.ijid.2020.10.065_bib0125","first-page":"S12","article-title":"Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy","volume":"189","author":"Nam","year":"2013","journal-title":"J Urol"},{"issue":"September (9)","key":"10.1016\/j.ijid.2020.10.065_bib0130","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1128\/AAC.47.9.2850-2858.2003","article-title":"Biological costs and mechanisms of fosfomycin resistance in Escherichia coli","volume":"47","author":"Nilsson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ijid.2020.10.065_bib0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41391-018-0032-2","article-title":"Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis","volume":"21","author":"Noreikaite","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"January (1)","key":"10.1016\/j.ijid.2020.10.065_bib0140","first-page":"18","article-title":"[Recommendations for best practice for prostate biopsy]","volume":"21","author":"Ouzzane","year":"2011","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"issue":"8","key":"10.1016\/j.ijid.2020.10.065_bib0145","article-title":"Antimicrobial therapy for chronic bacterial prostatitis","author":"Perletti","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"December (8)","key":"10.1016\/j.ijid.2020.10.065_bib0150","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ijmm.2017.09.019","article-title":"Biological cost of fosfomycin resistance in Escherichia coli in a murine model of urinary tract infection","volume":"307","author":"Pourbaix","year":"2017","journal-title":"Int J Med Microbiol IJMM"},{"issue":"July (7)","key":"10.1016\/j.ijid.2020.10.065_bib0155","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/jac\/dkv067","article-title":"Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis","volume":"70","author":"Rhodes","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"December (11\u201312)","key":"10.1016\/j.ijid.2020.10.065_bib0160","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.5489\/cuaj.3068","article-title":"The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: A prospective, randomized, and controlled clinical study","volume":"9","author":"Sen","year":"2015","journal-title":"Can Urol Assoc J J Assoc Urol Can"},{"issue":"October (5)","key":"10.1016\/j.ijid.2020.10.065_bib0165","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1179\/joc.2010.22.5.355","article-title":"Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection","volume":"22","author":"Senol","year":"2010","journal-title":"J Chemother Florence Italy"},{"issue":"December","key":"10.1016\/j.ijid.2020.10.065_bib0170","article-title":"Risk factors for infection after prostate biopsy in the United States","author":"Shoag","year":"2019","journal-title":"Urology"},{"issue":"July (4)","key":"10.1016\/j.ijid.2020.10.065_bib0175","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1517\/14740338.2013.796362","article-title":"Risks associated with the therapeutic use of fluoroquinolones","volume":"12","author":"Stahlmann","year":"2013","journal-title":"Expert Opin Drug Saf"},{"issue":"March (3)","key":"10.1016\/j.ijid.2020.10.065_bib0180","first-page":"391","article-title":"Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study","volume":"26","author":"Van Besien","year":"2019","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"issue":"October (10)","key":"10.1016\/j.ijid.2020.10.065_bib0185","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.ijid.2020.10.065_bib0190","first-page":"73","article-title":"Reducing infectious complications following transrectal ultrasound-guided prostate biopsy: a systematic review","volume":"18","author":"Walker","year":"2016","journal-title":"Rev Urol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220322694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220322694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:55:20Z","timestamp":1761119720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220322694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":38,"alternative-id":["S1201971220322694"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.10.065","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.10.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}